NMRA   $2.51  -2.33% Market Closed After Close 2.5392 1.16%

Neumora Therapeutics, Inc.
Total Cash 371.64M
totalCashPerShare 2.322
EBITDA -230.20M
Total Debt 3.61M
quickRatio 16.141
currentRatio 17.225
Total Revenue
debtToEquity 0.946
Revenue/Share
ROA -0.37750998
ROE -0.77081
grossProfits
freeCashflow -133.95M
operatingCashflow -198.33M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 1.42B
forwardPE -7.206452
floatShares 83.39M
sharesOutstanding 160.03M
sharesShort 9.01M
sharesShortPriorMonth 9.52M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.28%
heldPercentInstitutions 0.62%
Short Ratio help_outline 7.62%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 2.384
Price To Book help_outline 4.69
earningsQuarterlyGrowth
netIncomeToCommon -274.18M
trailingEps -1.72%
forwardEps -1.55%
enterpriseToEbitda -6.17
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.39 3Q 2024
institutionsCount 138
lastUpdated Nov. 2, 2024, 6:40 a.m.